COVID-19 Pneumonia Clinical Trials
2 recruiting trials for COVID-19 Pneumonia. Eligibility criteria explained in plain English.
TrialFinderData lists 2 COVID-19 Pneumonia clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Weill Medical College of Cornell University (1), Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Cardiac MRI (diagnostic_test, 1 trial), followed by Echocardiogram, 6-minute walk test.
Track COVID-19 Pneumonia trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
The purpose of this study is to test if visualizing the heart with cardiac MRI/echo will be important in the understanding cardiac function and prediction of cardiopulmonary...
AI-based System for Assessing Suspected Viral Pneumonia Related Lung Changes
The AI-based system designed to process chest computed tomography (CT) aims to 1) detect the presence of pathologic patterns associated with interstitial changes in pneumonia; 2)...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for COVID-19 Pneumonia, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for COVID-19 Pneumonia, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for COVID-19 Pneumonia, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.